A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
Clinical trial NCT04278729 · COMPLETED
Trial details
- NCT number
- NCT04278729
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2023-09-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.